Glycaemic control, treatment satisfaction and quality of life in type 2 diabetes patients in Greece: The PANORAMA study Greek results

Table 4 Diabetes treatment regimens in the PANORAMA study population

Treatment regimen	n (%)
No diet, no orals, no injectables (no available data)	10 (2.7)
Only diet and/or exercise	20 (5.3)
Only OADs	244 (65.1)
On oral plus insulin	63 (16.8)
Only on insulin	28 (7.5)
On GLP-1 analogues ± insulin1	10 (2.7)
Oral hypoglycaemic agents	316 (84.3)
Sylphonylureas	121 (32.3)
Meglitinides/Glinides	12 (3.2)
Biguanides	275 (73.3)
Thiazolidinediones	41 (10.9)
DPP-4 inhibitors	94 (25.1)
Alpha glucosidase inhibitors	13 (3.5)
Fixed-dose combinations	46 (12.3)
Thiazolidinediones + metformin	3 (6.5)
DPP4 inhibitors + metformin	43 (93.5)

¹One patient receiving a GLP-1 analogue and insulin was classified in the latter category making the total number of patients 91 when the number should have been 92. OAD: Oral anti-diabetes drugs.